Sapreme Appoints Björn Cochlovius as Chairman of its Board of Directors

UTRECHT, the Netherlands – Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the establishment of its independent Board of Directors by the appointment of Björn Cochlovius, Ph.D., as Chairman of the Board, effective immediately. “I have observed the rapid evolvement of the Company and am impressed by … Read more